Winfred
Back to Startups
MIP Diagnostics

MIP Diagnostics

MIP Diagnostics develops synthetic antibodies for use in diagnostic devices.

Bedfordshire, UK— Founded 2015— Website
£12.4MTotal raised

MIP Diagnostics is a nanotechnology business based in Bedfordshire that develops and manufactures synthetic antibodies known as nanoMIPs. These nanoscale polymers serve as robust alternatives to traditional antibodies for use in diagnostic devices and biosensors.

Categories

BioTech

Team

SA

Stephane Argivier

CEO

Stephane brings three decades of experience scaling life sciences companies. He currently leads Longitudinal and MIP Diagnostics, alongside board and advisory roles across the sector.

LinkedIn
JR

Jim Reid

Chairman

Investors

  1. Series A
    £7.3M
    Mercia Asset Management
    Mercia Asset Management    Follow-on
    Calculus Capital
    Calculus Capital    Follow-on
    Downing Ventures
    Downing Ventures    Follow-on
    BGF
    BGF    Follow-on
  2. Series A
    £5.1M
    Downing Ventures
    Downing Ventures    Lead
    BGF
    BGF    Lead
    Calculus Capital
    Calculus Capital    Lead
    Mercia Asset Management
    Mercia Asset Management

Funding history